ORIC ORIC PHARMACEUTICALS
Permanent stock page ↗Health Care · Russell 2000
Next earnings: Thu 12 Nov 2026 · estimated
What 15 analyst firms say about ORIC PHARMACEUTICALS: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 6 months
Analyst view · last 6M
14 rated views · 15 analyst/firm records · 15 firms
Radar score
- Russell 2000 · Top Picks · 6MGood · #44 in the index86
- Russell 2000 · Safest consensus · 6MBelow the Radar threshold of 8062
Recent analyst activity · last 90 days
Our tracked history has 10 reports on ORIC from 8 analyst firms in the last 90 days (21 firms in the past year).
Comparing each firm's latest target with its previous one: 2 raised their price target, 1 lowered it, 3 left it unchanged and 1 has its first observed target in the past year.
No firm's latest available rating differs from its previous one.
Latest observed target change: Wedbush lowered its target from $17.00 (set 1 Apr 2026) to $14.00 on 27 Oct 2026.
Last 6 months. Latest opinion per identifiable analyst within the last 6 months. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Benchmark | Unnamed analyst | Buy | 8 Jun 2026 | — |
| BTIG | Jeet Mukherjee | Buy | 28 Oct 2026 | 26.00 USD |
| Cantor Fitzgerald | Unnamed analyst | Buy | 22 May 2026 | — |
| Evercore ISI | Cory Kasimov | Buy | 4 Aug 2026 | 25.00 USD |
| Goldman Sachs | Corinne Johnson | Buy | 15 May 2026 | 15.00 USD |
| H.C. Wainwright | Robert Burns | Buy | 27 Oct 2026 | 27.00 USD |
| Jonestrading | Soumit Roy | Buy | 1 Jul 2026 | 25.00 USD |
| JPMorgan | Anupam Rama | Buy | 14 Oct 2026 | 26.00 USD |
| Leerink Partners | Asthika Goonewardene | Buy | 5 Oct 2026 | 26.00 USD |
| Piper Sandler | Kelsey Goodwin | Buy | 3 Aug 2026 | 22.00 USD |
| Stifel | Laura Prendergast | Buy | 26 Oct 2026 | 18.00 USD |
| Wedbush | David Nierengarten | Buy | 27 Oct 2026 | 14.00 USD |
| Weiss Ratings | Unnamed analyst | — | 15 Oct 2026 | — |
| Wells Fargo | Derek C Archila | Buy | 21 Sep 2026 | 25.00 USD |
| Data feed RESEARCH | Research Team | Hold | 15 Jun 2026 | — |
Partial coverage · checked 6 Nov (6 Nov 2026, 06:06 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.